Back to Nuveen, LLC Nuveen, LLC

ADMAADMA
6 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in ADMA BIOLOGICS INC

Yes. Nuveen Investments holds 3,260,349 shares of ADMA (Adma Biologics), worth $27.3M, as of its Q2 2026 13F filing. It reduced the position by 2,837,876 shares (-46.5%) from Q1 2026. Nuveen Investments has held ADMA in every 13F on record since Q1 2025, 6 quarterly filings.

Current Value

$27.3M

Current Shares

3.3M

Total Value Change

-$66.3M

Total Shares Change

-1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.3M
-46.5%
$27.3M0.0%$8.37
0
2026-Q1
Increased
6.1M
+2.9%
$54.9M0.0%$9.01
30
2025-Q4
Increased
5.9M
+3.5%
$108.1M0.0%$18.24
31
2025-Q3
Increased
5.7M
+2.9%
$83.9M0.0%$14.66
31
2025-Q2
Increased
5.6M
+18.0%
$101.3M0.0%$18.21
35
2025-Q1
First report
4.7M
-
$93.5M0.0%$19.84
0

Other major holders of ADMA: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used